Interleukin-33 affects cytokine production by keratinocytes in vitiligo

Clinical and Experimental Dermatology

Volumn 40, Issue 2, 2015, Pages 163-170

  Li, P ^a   Ma, H ^a   Han, D ^a   Mou, K ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN 33; INTERLEUKIN 6; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FIBROBLAST GROWTH FACTOR; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; UPREGULATION; VITILIGO; WESTERN BLOTTING; CASE CONTROL STUDY; CELL NUCLEUS; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL NUCLEUS; CYTOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INTERLEUKIN-6; INTERLEUKINS; KERATINOCYTES; MALE; MIDDLE AGED; STEM CELL FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VITILIGO;

EID: 84923116114     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12464     Document Type: Article

References (24)

1. Lee AY. Role of keratinocytes in the development of vitiligo. Ann Dermatol 2012; 24: 115-25.
2. Guerra L, Dellambra E, Brescia S, Raskovic D. Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab 2010; 11: 451-67.
3. Sviderskaya EV, Wakeling WF, Bennett DC. A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes. Development 1995; 121: 1547-57.
4. Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005; 18: 2-12.
5. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-90.
6. Chackerian AA, Oldham ER, Murphy EE et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007; 179: 2551-5.
7. Iikura M, Suto H, Kajiwara N et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007; 87: 971-8.
8. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-10.
9. Stolarski B, Kurowska-Stolarska M, Kewin P et al. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010; 185: 3472-80.
10. Haraldsen G, Balogh J, Pollheimer J et al. Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol 2009; 30: 227-33.
11. Balato A, Lembo S, Mattii M et al. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 2012; 21: 892-4.
12. Savinko T, Matikainen S, Saarialho-Kere U et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 2012; 132 : 1392-400.
13. Rankin AL, Mumm JB, Murphy E et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010; 184 : 1526-35.
14. Yin H, Li X, Hu S et al. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol Immunol 2013; 56: 347-53.
15. Kakkar R, Hei H, Dobner S, Lee RT. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 2012; 287: 6941-8.
16. Moretti S, Fabbri P, Baroni G et al. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 2009; 24: 849-57.
17. Lee AY, Youm YH, Kim NH et al. Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis. Br J Dermatol 2004; 151: 995-1003.
18. Schallreuter KU, Salem MA, Gibbons NC et al. Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: epidermal H2O2/ONOO (-)-mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling. FASEB J 2012; 26: 2471-85.
19. van den Boorn JG, Konijnenberg D, Dellemijn TA et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220-32.
20. Drube S, Heink S, Walter S et al. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. Blood 2010; 115: 3899-906.
21. Laddha NC, Dwivedi M, Begum R. Increased tumor necrosis factor (TNF)-alpha and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS ONE 2012; 7: e52298.
22. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004; 17: 96-110.
23. Alghamdi KM, Khurrum H, Taieb A, Ezzedine K. Treatment of generalized vitiligo with anti-TNF-alpha Agents. J Drugs Dermatol 2012; 11: 534-9.
24. Tsuboi R, Sato C, Shi CM et al. Endothelin-1 acts as an autocrine growth factor for normal human keratinocytes. J Cell Physiol 1994; 159: 213-20.